CPC A61K 31/436 (2013.01) [A61K 9/0014 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 47/18 (2013.01); A61K 47/22 (2013.01); A61K 47/24 (2013.01); A61K 47/28 (2013.01); A61K 47/34 (2013.01); A61K 47/38 (2013.01); A61K 45/06 (2013.01)] | 52 Claims |
1. An anhydrous composition of a mTOR inhibitor comprising:
about 0.1 wt % to about 20 wt % of rapamycin (sirolimus),
about 80 wt % to about 99.9 wt % of a solvent;
about 0.1 wt % to about 5 wt % of a gelling agent;
about 0.001 wt % to about 1 wt % of an antioxidant;
wherein the anhydrous composition is formulated for topical administration.
|